Positron-emission tomography as a prognostic tool for early-stage lung cancer
Authors:
- Robert WelshRWRobert Welsh
- Phillip J. BendickPBPhillip J. Bendick
- Gerald ZelenockGZGerald Zelenock
- Gary W. ChmielewskiGCGary W. Chmielewski
- 1 March 2006
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 191 (3) , 433-436
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Managing the Small Pulmonary Nodule Discovered by CTChest, 2004
- FDG uptake in breast cancer: correlation with biological and clinical prognostic parametersEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trialThe Lancet, 2002
- Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass LesionsJAMA, 2001
- [18F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer✩European Journal of Cardio-Thoracic Surgery, 2000
- Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s—Meta-analytic Comparison Of PET and CTRadiology, 1999
- The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinomaCancer, 1998
- Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucoseCancer, 1998
- Lung Cancer Screening: The Mayo ProgramJournal of Occupational and Environmental Medicine, 1986
- Survival and Mortality from Lung Cancer in a Screened PopulationChest, 1986